newsfilter
← Latest News
PR Newswire·

Elanco Announces Updates to Board of Directors

  • Elanco Animal Health announced that R. David Hoover and Deborah Kochevar will not stand for re-election at the May 2026 Annual Meeting of Shareholders.
  • Hoover, who joined as the first Chairman of the Board during the company's 2018 IPO, is retiring after eight years of service.
  • Kochevar is concluding her tenure after joining the Board in March 2019 following Elanco's separation from Eli Lilly and Company.
  • Chairman Lawrence E. Kurzius credited Hoover with establishing a robust governance framework & clear strategic direction during the company's transition to independence.
  • President & CEO Jeff Simmons stated that Hoover's leadership was instrumental in shaping Elanco into a global leader positioned for sustainable growth.
  • Kochevar is being thanked for her leadership of the Innovation, Science & Technology committee & her expertise in veterinary medicine.
  • Simmons noted Kochevar's guidance was vital to building the company's historical innovation momentum & current robust pipeline.
  • The Board of Directors will consist of nine members following these departures.